MEDICAL COLLEGE OF WISCONSIN
Discovery and development of novel HCMV inhibitors
Discovery and development of novel HCMV inhibitors is a funding opportunity from MEDICAL COLLEGE OF WISCONSIN, up to 762983, closing August 31, 2026.
Aug 31, 2026
(31d left)Overview
ABSTRACT Infection with human Cytomegalovirus (HCMV) is nearly universal; seroprevalence rates reach 90% in individuals older than 80. Although usually asymptomatic in the normal host, HCMV causes severe morbidity and mortality in transplant recipients and patients with AIDS. Congenital HCMV is the leading infectious…